End-to-End Machine Learning-Driven Design of Targeted Monoclonal Antibodies
Exclusively Licensed
Invention type: Technology
/
Case number: #24595L
Researchers
Matthew Walsh
/
Rajmonda Caceres
/
Rafael Jaimes
/
Lin Li
/
Esther Wolf
/
Will Spaeth
/
Leslie Shing
/
Tristan Bepler
Departments: Lincoln Laboratory
Technology Areas: Artificial Intelligence (AI) and Machine Learning (ML) / Drug Discovery and Research Tools: Antibodies / Therapeutics: Proteins & Antibodies
Impact Areas: Healthy Living
-
end-to-end machine learning-driven design of proteins
United States of America | Pending -
end-to-end machine learning-driven design of proteins
Singapore | Pending
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.